164 related articles for article (PubMed ID: 14744765)
1. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma.
Kondo T; Oue N; Yoshida K; Mitani Y; Naka K; Nakayama H; Yasui W
Cancer Res; 2004 Jan; 64(2):523-9. PubMed ID: 14744765
[TBL] [Abstract][Full Text] [Related]
2. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
Gao J; Zhang J; Long Y; Lu X
Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
[TBL] [Abstract][Full Text] [Related]
3. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer.
Fujii K; Sasahira T; Moriwaka Y; Oue N; Yasui W; Kuniyasu H
Int J Mol Med; 2008 May; 21(5):599-604. PubMed ID: 18425352
[TBL] [Abstract][Full Text] [Related]
4. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Butler KS; Hines WC; Heaphy CM; Griffith JK
Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
[TBL] [Abstract][Full Text] [Related]
5. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
6. Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells.
Gomez D; Wenner T; Brassart B; Douarre C; O'Donohue MF; El Khoury V; Shin-Ya K; Morjani H; Trentesaux C; Riou JF
J Biol Chem; 2006 Dec; 281(50):38721-9. PubMed ID: 17050546
[TBL] [Abstract][Full Text] [Related]
7. MiR-185 targets POT1 to induce telomere dysfunction and cellular senescence.
Li T; Luo Z; Lin S; Li C; Dai S; Wang H; Huang J; Ma W; Songyang Z; Huang Y
Aging (Albany NY); 2020 Jul; 12(14):14791-14807. PubMed ID: 32687062
[TBL] [Abstract][Full Text] [Related]
8. POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells.
Ning X; Yang S; Wang R; Zhang R; Guo L; Tie J; Cheng Y; Wang G; Wan S; Fang D
Eur J Cancer Prev; 2010 Sep; 19(5):345-51. PubMed ID: 20517159
[TBL] [Abstract][Full Text] [Related]
9. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
Lin X; Gu J; Lu C; Spitz MR; Wu X
Clin Cancer Res; 2006 Oct; 12(19):5720-5. PubMed ID: 17020976
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.
Yamada M; Tsuji N; Nakamura M; Moriai R; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2002; 22(6A):3303-7. PubMed ID: 12530079
[TBL] [Abstract][Full Text] [Related]
11. Distinct requirements for Pot1 in limiting telomere length and maintaining chromosome stability.
Bunch JT; Bae NS; Leonardi J; Baumann P
Mol Cell Biol; 2005 Jul; 25(13):5567-78. PubMed ID: 15964812
[TBL] [Abstract][Full Text] [Related]
12. G-quadruplex-mediated regulation of telomere binding protein POT1 gene expression.
He Q; Zeng P; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta; 2014 Jul; 1840(7):2222-33. PubMed ID: 24631651
[TBL] [Abstract][Full Text] [Related]
13. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Kitadai Y; Haruma K; Chayama K; Tahara E; Yasui W
Pathobiology; 2001; 69(4):219-24. PubMed ID: 12007281
[TBL] [Abstract][Full Text] [Related]
14. Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features.
Izgi A; Gunal A; Yalcin S; Gunduz U
Biomed Pharmacother; 2014 Sep; 68(7):841-6. PubMed ID: 25194444
[TBL] [Abstract][Full Text] [Related]
15. Telomere shortening occurs early during gastrocarcinogenesis.
Mu Y; Zhang Q; Mei L; Liu X; Yang W; Yu J
Med Oncol; 2012 Jun; 29(2):893-8. PubMed ID: 21359861
[TBL] [Abstract][Full Text] [Related]
16. Human POT1 facilitates telomere elongation by telomerase.
Colgin LM; Baran K; Baumann P; Cech TR; Reddel RR
Curr Biol; 2003 May; 13(11):942-6. PubMed ID: 12781132
[TBL] [Abstract][Full Text] [Related]
17. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
18. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activation without shortening of telomeric 3'-overhang is a poor prognostic factor in human colorectal cancer.
Kojima K; Hiyama E; Otani K; Ohtaki M; Fukuba I; Fukuda E; Sueda T; Hiyama K
Cancer Sci; 2011 Feb; 102(2):330-5. PubMed ID: 21108695
[TBL] [Abstract][Full Text] [Related]
20. Time-Dependent Effects of POT1 Knockdown on Proliferation, Tumorigenicity, and HDACi Response of SK-OV3 Ovarian Cancer Cells.
Zhou H; Mondal A; Dakic A; Alhawas L; Liu X; He Z
Biomed Res Int; 2018; 2018():7184253. PubMed ID: 29546066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
